About: Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q- and 17p-)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q- and 17p-) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) article scientifique publié en 2005 (fr) наукова стаття, опублікована в листопаді 2005 (uk) im November 2005 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q58865938-C3350200-0A87-49D9-A865-76A1137B0A59
publication date	2005-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58865938-96C7ED3E-94EB-4EDF-A167-B0528CE91234
language of work or name	English
author name string	wds:Q58865938-337382BB-E37F-4EB2-86F1-B9D6EE6795DC wds:Q58865938-3A58B855-B450-4081-9312-916076D32CF0 wds:Q58865938-493CBC38-54FB-4CBB-A6E8-EC0765474D0B wds:Q58865938-5F77E31A-15A3-436B-BE35-B6F1C1DA010C wds:Q58865938-6C5967A5-2CB7-487C-8D12-4BAEEA32AB90 wds:Q58865938-A78846F3-918C-49CF-834D-624160326629 wds:Q58865938-BBF65FFE-5B36-4439-896C-1F8E105CC809 wds:Q58865938-F30B2EB9-8560-4A39-9884-99E734396D6D wds:Q58865938-FD14EEFE-BCF7-4E5F-BB7E-F7153A65DBAF
author name string	Rodrigo Martino Marcos González Dolores Caballero Rafael Cabrera Jorge Sierra Angel León Jose A García-Marco José Sarrá Victoria Mateos
rdfs:label	Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q- and 17p-) (en) Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (nl)
skos:prefLabel	Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q- and 17p-) (en) Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (nl)
name	Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q- and 17p-) (en) Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (nl)
author	wds:Q58865938-4B8A6F1A-9620-445D-B32A-7D7176993DAA wds:Q58865938-596ECEE2-623A-4A3C-9227-157EABCD227A wds:Q58865938-80EB4C8D-7866-4BB8-8987-8F6BA76999F0 wds:Q58865938-B5F2CE67-9246-492F-B457-A4F66A642D15
author	Guillermo F Sanz Jesús San Miguel Josep-Maria Ribera Javier de la Serna
title	wds:Q58865938-B00B54E2-FAB3-433B-A2F1-836E217567CF
title	Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-) (en)
page(s)	wds:Q58865938-B60DBB9F-4EDB-420C-81FF-52FCD822580B
page(s)	7757-7763
instance of	wds:Q58865938-DDB89F7C-FD46-4DE7-BB33-51B1D40D4B1B
instance of	scholarly article
main subject	wds:Q58865938-28A4F5AF-4636-4B67-BB2D-3A5FE2F9DA22 wds:Q58865938-35C3D0A2-AF9A-48B7-80F7-5B308A69A6ED
main subject	leukemia B-cell chronic lymphocytic leukemia
PubMed ID	wds:Q58865938-D4FD7D5D-463B-487A-943A-CA6523FD09ED
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16278397
PubMed ID	16278397
published in	wds:Q58865938-AB42147F-5A39-4510-8BF8-EEB20CC086CF
published in	Clinical Cancer Research
issue	wds:Q58865938-0A24D772-AB40-4539-AD17-AA9F5D6CAC78
volume	wds:Q58865938-F8BDB8EA-7709-4164-806A-85D811E58A78
issue	21
volume	11
DOI	wds:Q58865938-6B7EC08F-E720-4024-AFD9-8ED8C7899B19
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-05-0941
DOI	10.1158/1078-0432.CCR-05-0941
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58865938
is cites work of	Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia? Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia Hematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimens Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning Optimal pharmacotherapeutic management of chronic lymphocytic leukaemia: considerations in the elderly Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime? Eradicating minimal residual disease in chronic lymphocytic leukemia: should this be the goal of treatment? Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet Emerging therapy for chronic lymphocytic leukaemia Graft-versus-leukemia in chronic lymphocytic leukemia Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome Chronic lymphocytic leukaemia Therapeutic advancement of chronic lymphocytic leukemia Patterns of patient specific dosimetry in total body irradiation Treatment of fludarabine-refractory chronic lymphocytic leukemia Update on risk-stratified management for chronic lymphocytic leukemia Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia The role of stem cell transplantation in the management of chronic lymphocytic leukaemia Reduced intensity versus full myeloablative stem cell transplant for advanced CLL. Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis Predictors of outcome in reduced intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: summarizing the evidence and highlighting the limitations Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group Chronic lymphocytic leukemia: biology and current treatment Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia Allogeneic transplantation for chronic lymphocytic leukemia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software